Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cimpress (CMPR) Research & Development (2016 - 2025)

Cimpress (CMPR) has 17 years of Research & Development data on record, last reported at $89.1 million in Q4 2025.

  • For Q4 2025, Research & Development rose 7.48% year-over-year to $89.1 million; the TTM value through Dec 2025 reached $343.3 million, up 3.26%, while the annual FY2025 figure was $334.0 million, 3.75% up from the prior year.
  • Research & Development reached $89.1 million in Q4 2025 per CMPR's latest filing, up from $84.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $89.1 million in Q4 2025 and bottomed at -$136.8 million in Q2 2021.
  • Average Research & Development over 5 years is $67.5 million, with a median of $79.1 million recorded in 2023.
  • Peak YoY movement for Research & Development: tumbled 336.08% in 2021, then soared 158.47% in 2022.
  • A 5-year view of Research & Development shows it stood at $70.3 million in 2021, then rose by 10.61% to $77.7 million in 2022, then grew by 2.88% to $80.0 million in 2023, then increased by 3.65% to $82.9 million in 2024, then rose by 7.48% to $89.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $89.1 million in Q4 2025, $84.9 million in Q3 2025, and $86.2 million in Q2 2025.